Table 2.

Induction of amenorrhea

1.	GnRH agonist (3.75 mg/month subcutaneous leuprolide acetate, in general), enabling
	a. induction of amenorrhea
	b. “parenteral” contraceptive effect effective even in patients with vomiting
	c. possible anti-apoptotic, protective effect on the follicles, observed in animal studies but not yet in women.
2.	In order to avoid flare-ups, it is recommended to prescribe
	a. a contraceptive pill 10 to 15 days after the agonist injection
	b. or a macroprogestin for the first month.